companydata.dkcompanydata.dk

Reumatolog Khurram Ashraf ApS: Financial statements 2020

CVR: 39336081

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

Reumatolog Khurram Ashraf ApS (CVR 39336081) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 354,371 and a net result of DKK 278,717 compared with DKK 127,672 the year before. That is an increase of 114.2% compared with the year before. Equity in the 2020 report amounted to DKK 319,303. The solvency ratio was 65.7%.

Gross Profit
DKK 354,371
Profit/Loss
DKK 278,717
Equity
DKK 319,303
Total Assets
DKK 486,281

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-354K279K319K-
2019-165K128K165K-
2018-48K37K37K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Reumatolog Khurram Ashraf ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Reumatolog Khurram Ashraf ApS: The 2019 annual report is outMay 19, 2020

Reumatolog Khurram Ashraf ApS has published its annual report for 2019. Gross profit came to DKK 165,474, and the net result was DKK 127,672.

About Reumatolog Khurram Ashraf ApS

Reumatolog Khurram Ashraf ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2018. The company is registered under the industry Alment praktiserende lægers aktiviteter. The company was previously named Reumatolog Khurram Ashraf IVS. The management consists of Khurram Ashraf. The company is owned by Speciallægen FZJ Holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 633,663 and a net result of DKK 130,666 compared with DKK 46,332 the year before. Equity in the 2025 report amounted to DKK 52,832.

Source: annual report 2025, Danish Business Authority

Other financial years